The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Open accessAbstract
Diabetes and related complications are associated with long-term damage and failure of various organ systems. The line of demarcation between the pathogenic mechanisms of microvascular and macrovascular complications of diabetes and differing responses to therapeutic interventions is blurred. Diabetes induces changes in the microvasculature, causing extracellular matrix protein synthesis, and capillary basement membrane thickening which are the pathognomic features of diabetic microangiopathy. These changes in conjunction with advanced glycation end products, oxidative stress, low grade inflammation, and neovascularization of vasa vasorum can lead to macrovascular complications. Hyperglycemia is the principal cause of microvasculopathy but also appears to play an important role in causation of macrovasculopathy. There is thought to be an intersection between micro and macro vascular complications, but the two disorders seem to be strongly interconnected, with micro vascular diseases promoting atherosclerosis through processes such as hypoxia and changes in vasa vasorum. It is thus imperative to understand whether microvascular complications distinctly precede macrovascular complications or do both of them progress simultaneously as a continuum. This will allow re-focusing on the clinical issues with a unifying perspective which can improve type 2 diabetes mellitus outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“A relative risk (RR) reduction in myocardial infarction (MI) ( P = 0.052) has been observed in the 10 years of posttrial follow‑up of UKPDS.”
InfluentialIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“[6] The action in diabetes and vascular disease: Preterax and Diamicron MR Controlled Evaluation and the Veterans Affairs Diabetes Trial failed to show any significant improvement in cardiovascular risk with the intensification of diabetes therapy.[7,8] To further complicate matters, in Action to Control Cardiovascula…”
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Microvascular and Macrovascular Complications of Diabetes
Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.2.77 · Cited by 1,954
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Wong, T. Y., Klein, R., Couper, D. J., Cooper, L. S., Shahar, E., Hubbard, L. D., Wofford, M. R., & Sharrett, A. R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06253-5 · Cited by 781
Fong, D. S., Aiello, L. P., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2540 · Cited by 640
Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., & Stern, D. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1521 · Cited by 635
Girard, B. (2008) · Cited by 616
Rema, M., Premkumar, S., Anitha, B., Deepa, R., Pradeepa, R., & Mohan, V. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0019 · Cited by 520
The Pathologic Continuum of Diabetic Vascular Disease
Orasanu, G., & Plutzky, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.055 · Cited by 487
Kalousová, M., Škrha, J., & Zima, T. (2002) · Physiological Research · doi:10.33549/physiolres.930234 · Cited by 455
Standards of Medical Care in Diabetes—2016: Summary of Revisions
(2016) · Diabetes Care · doi:10.2337/dc16-s003 · Cited by 448
Hovind, P., Tarnow, L., Rossing, P., Graae, M., Torp, I., Binder, C., & Parving, H.-H. (2004) · BMJ · doi:10.1136/bmj.38070.450891.fe · Cited by 432
Folli, F., Corradi, D., Fanti, P., Davalli, A., Paez, A., Giaccari, A., Perego, C., & Muscogiuri, G. (2011) · Current Diabetes Reviews · doi:10.2174/157339911797415585 · Cited by 376
Advanced glycation end-products and the progress of diabetic vascular complications.
Jakuš, V, & Rietbrock, N. (2004) · Physiological Research · doi:10.33549/physiolres.930430 · Cited by 341
Prevalence of Diabetic Retinopathy in India
Raman, R., Rani, P. K., Reddi Rachepalle, S., Gnanamoorthy, P., Uthra, S., Kumaramanickavel, G., & Sharma, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.09.010 · Cited by 323
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
and the WHO Multinational Study Group, Fuller, J., Stevens, L., & Wang, S.-L. (2001) · Diabetologia · doi:10.1007/pl00002940 · Cited by 301
Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization
Gao, G., Li, Y., Zhang, D., Gee, S., Crosson, C., & Ma, J.-X. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02110-x · Cited by 297
Prevalence and Risk Factors of Diabetic Nephropathy in an Urban South Indian Population
Unnikrishnan, R., Rema, M., Pradeepa, R., Deepa, M., Shanthirani, C. S., Deepa, R., & Mohan, V. (2007) · Diabetes Care · doi:10.2337/dc06-2554 · Cited by 278
Kilhovd, B. K., Berg, T. J., Birkeland, K. I., Thorsby, P., & Hanssen, K. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1543 · Cited by 269
Trevisan, R., Dodesini, A. R., & Lepore, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121320 · Cited by 247
Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe
Soedamah-Muthu, S. S., Chaturvedi, N., Witte, D. R., Stevens, L. K., Porta, M., Fuller, J. H., & for the EURODIAB Prospective Complications Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0107 · Cited by 237
The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)
Charbonnel, B., Dormandy, J., Erdmann, E., Massi-Benedetti, M., Skene, A., & PROactive Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1647 · Cited by 231
Bansal, D., Gudala, K., Muthyala, H., Esam, H. P., Nayakallu, R., & Bhansali, A. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12223 · Cited by 220
Retinal microvascular signs and risk of stroke and stroke mortality
Mitchell, P., Wang, J. J., Wong, T. Y., Smith, W., Klein, R., & Leeder, S. R. (2005) · Neurology · doi:10.1212/01.wnl.0000179177.15900.ca · Cited by 215
Mitochondrial dysfunction in diabetic cardiomyopathy
Duncan, J. G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.014 · Cited by 208
Yatsuya, H., Folsom, A. R., Wong, T. Y., Klein, R., Klein, B. E. K., & Sharrett, A. R. (2010) · Stroke · doi:10.1161/strokeaha.110.580837 · Cited by 200
Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.
Kalofoutis, C., Piperi, C., Kalofoutis, A., Harris, F., Phoenix, D. A., & Singh, J. (2007) · PubMed · Cited by 182
Raman, R., Ganesan, S., Pal, S. S., Kulothungan, V., & Sharma, T. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2013-000005 · Cited by 174
Vasa Vasorum in Atherosclerosis and Clinical Significance
Xu, J., Lu, X., & Shi, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511574 · Cited by 171
Krentz, A. J., Clough, G., & Byrne, C. D. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00670.x · Cited by 168
Hayden, M. R., & Tyagi, S. C. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-1 · Cited by 146
Nirmalan, P. K., Tielsch, J. M., Katz, J., Thulasiraj, R. D., Krishnadas, R., Ramakrishnan, R., & Robin, A. L. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0830 · Cited by 120
Hägg-Holmberg, S., Thorn, L. M., Putaala, J., Liebkind, R., Harjutsalo, V., Forsblom, C. M., Gordin, D., Tatlisumak, T., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0669 · Cited by 113
Heart in Diabetes: A Microvascular Disease
Laakso, M. (2011) · Diabetes Care · doi:10.2337/dc11-s209 · Cited by 112
Targher, G., Bertolini, L., Zenari, L., Lippi, G., Pichiri, I., Zoppini, G., Muggeo, M., & Arcaro, G. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02327.x · Cited by 101
Lloyd, C. E., Klein, R., Maser, R. E., Kuller, L. H., Becker, D. J., & Orchard, T. J. (1995) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)00039-q · Cited by 95
Ikmal, S. I. Q. S., Huri, H. Z., Vethakkan, S. R., & Ahmad, W. A. W. (2013) · International Journal of Endocrinology · doi:10.1155/2013/698567 · Cited by 93
Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta
Otsuka, A., Azuma, K., Iesaki, T., Sato, F., Hirose, T., Shimizu, T., Tanaka, Y., Daida, H., Kawamori, R., & Watada, H. (2005) · Diabetologia · doi:10.1007/s00125-005-0005-6 · Cited by 86
Xie, L., Zhu, X., Hu, Y., Li, T., Gao, Y., Shi, Y., & Tang, S. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1364 · Cited by 86
Tong, P. C. Y., Kong, A. P. S., So, W., Ng, M. H. L., Yang, X., Ng, M. C. Y., Ronald, C. W., Ho, C. S., Lam, C. W. K., Chow, C., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0887 · Cited by 74
ADVANCE: action in diabetes and vascular disease
Patel, A. A., Chalmers, J. P., & Poulter, N. R. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001890 · Cited by 53
Bonnefond, A., Saulnier, P., Stathopoulou, M. G., Grarup, N., Ndiaye, N. C., Roussel, R., Azimi–Nezhad, M., Dechaume, A., Lantieri, O., Herçberg, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055921 · Cited by 50
Tian, J., Hu, S., Sun, Y., Yu, H., Han, X., Cheng, W., Ban, X., Zhang, S., Yu, B., & Jang, I. (2012) · Heart · doi:10.1136/heartjnl-2012-302775 · Cited by 33
Epidemiology of diabetic neuropathy
Tapp, R. J., & Shaw, J. E. (2009) · Cited by 31
Does the Role of Angiogenesis Play a Role in Atherosclerosis and Plaque Instability?
Instability, A. (2013) · Anatomy & Physiology · doi:10.4172/2161-0940.1000147 · Cited by 14
Matheus, A. S. D. M., & Gomes, M. B. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-222 · Cited by 11
Cited by
AL-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9090430 · Cited by 741
The Growing Epidemic of Diabetes Mellitus
Lovic, D., Piperidou, A., Zografou, I., Grassos, H., Pittaras, A., & Manolis, A. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405165911 · Cited by 504
Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention
Wong, N. D., & Sattar, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00877-z · Cited by 495
Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
Yang, J., & Liu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816400 · Cited by 281
Dahlén, A. D., Dashi, G., Maslov, I., Attwood, M. M., Jonsson, J., Trukhan, V., & Schiöth, H. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.807548 · Cited by 275
Metadata
- Authors
- Chawla, R., Chawla, A., & Jaggi, S.
- Venue
- Indian Journal of Endocrinology and Metabolism
- Publisher
- Medknow
- Published
- 2016
- Volume
- 20
- Issue
- 4
- Pages
- 546
- ISSN
- 2230-8210 (ISSN-L)
- OpenAlex
- W2409181047
- Cited by
- 1,106
- References
- 58
- FWCI
- 64.66
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.